TCI GENE Inc. (TPEX:6879)
Taiwan
· Delayed Price · Currency is TWD 37.00
-0.20 (-0.54%)
Apr 29, 2026, 11:36 AM CST
TCI GENE Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Revenue | 273.61 | 347.54 | 333.86 | 424.02 | 432.22 | Upgrade
|
| Revenue Growth (YoY) | -21.27% | 4.10% | -21.27% | -1.90% | 124.01% | Upgrade
|
| Cost of Revenue | 121.02 | 143.47 | 159.24 | 180.66 | 192.79 | Upgrade
|
| Gross Profit | 152.59 | 204.07 | 174.62 | 243.36 | 239.43 | Upgrade
|
| Selling, General & Admin | 99.83 | 114.17 | 122.98 | 89.93 | 66.4 | Upgrade
|
| Research & Development | 33.68 | 34.14 | 45.62 | 62.33 | 59.46 | Upgrade
|
| Operating Expenses | 131.65 | 151.57 | 168.69 | 152.8 | 126.18 | Upgrade
|
| Operating Income | 20.93 | 52.5 | 5.93 | 90.56 | 113.25 | Upgrade
|
| Interest Expense | -1.4 | -0.5 | -1.18 | -0.85 | -0.84 | Upgrade
|
| Interest & Investment Income | 56.9 | 37.81 | 9.67 | 3.64 | 0.23 | Upgrade
|
| Earnings From Equity Investments | -8.12 | -9.35 | -5.86 | -3.45 | - | Upgrade
|
| Currency Exchange Gain (Loss) | 0.09 | 0.05 | -0.07 | -0.69 | -0.24 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.43 | 0.17 | 0.22 | 0.68 | 5.96 | Upgrade
|
| EBT Excluding Unusual Items | 67.97 | 80.68 | 8.71 | 89.89 | 118.36 | Upgrade
|
| Gain (Loss) on Sale of Investments | -29.06 | -20.15 | - | - | -1.94 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.06 | 7.03 | - | 0.24 | 0.01 | Upgrade
|
| Other Unusual Items | - | - | 0.06 | - | - | Upgrade
|
| Pretax Income | 38.97 | 67.56 | 8.78 | 90.13 | 116.44 | Upgrade
|
| Income Tax Expense | -0.11 | 11.03 | -8.18 | 15.79 | 24.29 | Upgrade
|
| Earnings From Continuing Operations | 39.08 | 56.53 | 16.95 | 74.34 | 92.14 | Upgrade
|
| Minority Interest in Earnings | 1.49 | -0.21 | -5.28 | -2.19 | 0.31 | Upgrade
|
| Net Income | 40.57 | 56.31 | 11.67 | 72.15 | 92.45 | Upgrade
|
| Net Income to Common | 40.57 | 56.31 | 11.67 | 72.15 | 92.45 | Upgrade
|
| Net Income Growth | -27.96% | 382.40% | -83.82% | -21.96% | 158.63% | Upgrade
|
| Shares Outstanding (Basic) | 26 | 26 | 26 | 24 | 19 | Upgrade
|
| Shares Outstanding (Diluted) | 27 | 27 | 26 | 25 | 20 | Upgrade
|
| Shares Change (YoY) | 0.30% | 0.18% | 7.71% | 24.22% | 5.74% | Upgrade
|
| EPS (Basic) | 1.53 | 2.13 | 0.44 | 2.95 | 4.84 | Upgrade
|
| EPS (Diluted) | 1.52 | 2.12 | 0.44 | 2.93 | 4.67 | Upgrade
|
| EPS Growth | -28.30% | 381.82% | -84.98% | -37.26% | 144.50% | Upgrade
|
| Free Cash Flow | 150.91 | 54.4 | 15.46 | 96.4 | 96.39 | Upgrade
|
| Free Cash Flow Per Share | 5.67 | 2.05 | 0.58 | 3.92 | 4.87 | Upgrade
|
| Dividend Per Share | - | 2.000 | 1.000 | 2.000 | 2.028 | Upgrade
|
| Dividend Growth | - | 100.00% | -50.00% | -1.36% | - | Upgrade
|
| Gross Margin | 55.77% | 58.72% | 52.30% | 57.39% | 55.40% | Upgrade
|
| Operating Margin | 7.65% | 15.11% | 1.78% | 21.36% | 26.20% | Upgrade
|
| Profit Margin | 14.83% | 16.20% | 3.50% | 17.01% | 21.39% | Upgrade
|
| Free Cash Flow Margin | 55.16% | 15.65% | 4.63% | 22.73% | 22.30% | Upgrade
|
| EBITDA | 26.61 | 59.79 | 15.11 | 112.07 | 145.86 | Upgrade
|
| EBITDA Margin | 9.73% | 17.20% | 4.53% | 26.43% | 33.75% | Upgrade
|
| D&A For EBITDA | 5.68 | 7.29 | 9.18 | 21.51 | 32.61 | Upgrade
|
| EBIT | 20.93 | 52.5 | 5.93 | 90.56 | 113.25 | Upgrade
|
| EBIT Margin | 7.65% | 15.11% | 1.78% | 21.36% | 26.20% | Upgrade
|
| Effective Tax Rate | - | 16.33% | - | 17.52% | 20.86% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.